Related Experiment Video
Updated: Mar 1, 2026

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice
Published on: May 16, 2019
Neuropeptides: A promising target for treating seizures
Neethi Menon1, Kedar S Prabhavalkar1, Lokesh K Bhatt1
1SVKM's Dr Bhanuben Nanavati College of Pharmacy, Vile Parle (W), Mumbai-56, India.
Neuropeptides can help manage seizures by correcting neurotransmitter imbalances. This review explores neuropeptides as potential therapeutic targets for seizure disorders and epileptogenesis.
Area of Science:
- Neuroscience
- Neurology
- Pharmacology
Background:
- Seizures affect 50 million people globally, stemming from neuronal firing imbalances.
- Excitatory and inhibitory neurotransmitter dysregulation underlies seizure activity.
- Neuropeptides are implicated in regulating neurotransmitter balance.
Purpose of the Study:
- To review neuropeptides that can alleviate seizure effects.
- To explore neuropeptides' role in managing epileptogenesis.
- To identify neuropeptides as potential therapeutic targets for seizure management.
Main Methods:
- Literature review of neuropeptide function in neurological disorders.
- Analysis of neuropeptide storage and release mechanisms.
- Focus on neuropeptides modulating excitatory/inhibitory neurotransmission.
Main Results:
- Certain neuropeptides demonstrate potential in rectifying neurotransmitter imbalances.
- Neuropeptides can mitigate seizure-related neuronal hyperexcitability.
- Evidence suggests neuropeptides can impact epileptogenesis.
Conclusions:
- Neuropeptides offer a promising avenue for seizure management.
- Targeting neuropeptides may provide novel therapeutic strategies for epilepsy.
- Further research into neuropeptide-based treatments is warranted.
Related Concept Videos
Antiepileptic Drugs: Glutamate Antagonists
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
Antiepileptic Drugs: Sodium Channel Blockers
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Antiepileptic Drugs: Calcium Channel Blockers
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...

